---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-060675"
form_type: "8-K"
ticker: "CPHI"
cik: "0001106644"
company_name: "CHINA PHARMA HOLDINGS, INC."
filed_at: "2022-09-30T23:59:59+00:00"
generated_at: "2026-06-23T06:16:17.016077+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# China Pharma (CPHI) gets NYSE American deficiency notice; avg price below $0.20, must cure by March 2023

## Summary
- Average stock price below $0.20 over 30 days as of Sept 22, 2022 triggers continued listing noncompliance.
- NYSE American requires reverse stock split or sustained price improvement by March 26, 2023 to maintain listing.
- Company also subject to prior stockholders' equity noncompliance letter from June 2022.
- Stock continues trading on NYSE American while company pursues compliance measures.

## SEC filing metadata
- accession: 0001213900-22-060675
- form_type: 8-K
- ticker: CPHI
- cik: 0001106644
- company_name: CHINA PHARMA HOLDINGS, INC.
- filed_at: 2022-09-30T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1106644/000121390022060675/0001213900-22-060675-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1106644/000121390022060675/ea166544-8k_chinapharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-060675
- JSON: https://secwatch.observer/filing/0001213900-22-060675.json
- Plain text: https://secwatch.observer/filing/0001213900-22-060675.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.